Updated Jul 16, 2026
BOLL ANDREW R. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $105K.
Andrew R. Boll is the President and Chief Financial Officer of Harrow, Inc., an eyecare pharmaceutical company focused on ophthalmic products. He has been involved in the company's financial operations and strategic direction.
| Role | PRESIDENT AND CFO |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | HROW | HARROW, INC. | P — Open-market purchase | 3.5K | $29.90 | $105K |
| 2025-12-17 | HROW | HARROW, INC. | F — Tax withholding / forfeiture | 26.7K | $47.06 | $1.25M |
| 2025-12-17 | HROW | HARROW, INC. | M — Option exercise | 60.0K | $3.95 | $237K |
| 2025-12-16 | HROW | HARROW, INC. | F — Tax withholding / forfeiture | 26.7K | $47.06 | $1.25M |
| 2025-12-16 | HROW | HARROW, INC. | M — Option exercise | 60.0K | $3.95 | $237K |
Andrew R. Boll is the President and Chief Financial Officer of Harrow, Inc., an eyecare pharmaceutical company focused on ophthalmic products. He has been involved in the company's financial operations and strategic direction.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($105K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live BOLL ANDREW R. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.